Closed Loop Medicine Launches First Personalized GLP-1 Dosing Platform in U.S.
September 19, 2025
Informed by 29 studies and 15,000+ patient profiles; developed to tailor GLP-1 titration and reduce side effects. Closed Loop Medicine Ltd (CLM), a leader in